National Integrated Medical Imaging System [NIMIS] extended to increase its geographical reach across Ireland

DUBLIN, Dec. 17, 2014 – McKesson has been awarded a contract extension to deliver the National Integrated Medical Imaging System (NIMIS) to an additional seven hospitals in Ireland. NIMIS, part of the Health Service Executive’s (HSE) Transformation Programme, is a national award-winning project that is currently transforming the delivery of imaging services across Ireland by implementing advanced medical technology within hospitals to ensure patients receive the best diagnostic solutions available in their treatment. With this extension, NIMIS will be delivered to 46 hospitals (63 distinct facilities), which will account for nearly 80 percent of the public hospitals across Ireland. Currently 33 hospitals (over 50 facilities) are live, with all hospitals expected to be live by end 2016.

NIMIS was initiated by HSE in 2008 with the objective of making Ireland’s hospitals paperless and filmless in radiology. Following a competitive tender process, the contract was awarded to the Imaging & Workflow Solutions Group of McKesson. The project involves the implementation of a fully integrated picture archiving and communication system (PACS) and radiology information system (RIS) across public hospitals in Ireland. Also being implemented is a fully integrated speech recognition system for the rapid production of radiology reports.

“With NIMIS, Ireland has one of the most advanced and integrated radiology IT infrastructures in the world,” says Professor Neil O’Hare, NIMIS Project Lead, HSE. “We are immensely excited about the transformation that is taking place within Ireland; the benefits to patients, health care professionals and our overall health care infrastructure are being increasingly widely recognised, which is why we are so pleased that these additional seven hospitals have chosen to join the programme.”

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.